-
Trial Underway Testing Bioelectronic Incontinence Device
The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate.
-
Damaged Human Lungs Restored for Transplantation
A research team demonstrated the feasibility of connecting anesthetized pigs to human lungs deemed unfit for transplants, for recovering the lungs to transplant quality.
-
Infographic – Digital Health Venture Funds Crater in Q4 2022
Venture funds for new companies developing digital solutions for health care continued dropping throughout 2022, reaching their lowest levels in years in the fourth quarter.
-
Types of Tax Forms for Businesses
This post lists the major tax forms a business owner should consider while preparing tax information.
-
Psychedelic Drug Shown to Relieve PTSD Brain Signals
A small clinical trial shows psychotherapy with the psychedelic drug MDMA generates brain signals that help relieve symptoms in people with post-traumatic stress disorder.
-
Real-World Data Shown to Match Eye Disease Trial Results
Research findings show data in patients’ electronic health records can be collected and analyzed to replicate results from late-stage clinical trials of an eye disease biologic drug.
-
QuickDNA Tests Meet International Lab Industry Standards
For laboratory tests with enormous consequences to their subjects, it’s vital that the labs conducting the tests meet exacting standards for quality and reliability.
-
Biotech, Academic Lab Partner on Microbiome-Safe Products
A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues.
-
Trial to Assess At-Home Asthma Lung Function Tests
A clinical trial is set to begin that compares monitoring of lung functions in people with asthma using portable ultrasound and mobile app at home to conventional tests in a clinic.
-
Nasal Spray Vaccine Shown to Stop Gonorrhea Infections
A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine.